P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about orforglipron as a potential treatment for adults with obesity or overweight, regulatory submission and action timing, and the timeline for future readouts, presentations, and other milestones relating to orforglipron and its clinical trials and reflects Lilly's current beliefs and expectations
Additionally, improvements in glycemic control, inflammation, and psychological well-being associated with GLP-1 therapy might secondarily affect stress physiology without directly suppressing cortisol secretion
Will my insurance cover it
Compounded formulations differ by pharmacy and product always check the specific instructions for your vial
Subsequently, the text is cleaned further by removing English stop words, punctuation, capitalization, special characters, and duplicate posts
Theyre for patients with very low levels of vitamin B12 or certain health issues